莫达非尼治疗与动脉瘤性蛛网膜下腔出血后精神状态:综合卒中中心分析
本研究在综合卒中中心评估莫达非尼对动脉瘤性蛛网膜下腔出血后精神状态的影响,21%(88/422)患者接受莫达非尼(100-200 mg/天),87.5%(77/88)在72小时内精神状态改善,倾向性评分匹配后莫达非尼组出院时格拉斯哥昏迷量表评分平均变化大于无莫达非尼组(2.2 vs -0.2,P=0.003)。
要点
- 21%(88/422)的aSAH患者接受莫达非尼,中位起始时间为aSAH后14天,中位疗程10.5天。
- 87.5%(77/88)的莫达非尼使用者在72小时内精神状态改善,出院时86.4%(76/88)改善。
- 匹配后莫达非尼组出院时GCS评分平均变化2.2 vs 无莫达非尼组-0.2(P=0.003)。
核心结论
- 大多数接受莫达非尼的aSAH患者观察到精神状态改善的时间关系,不良反应谱良好,作者认为在急性期可考虑低阈值起始莫达非尼。
研究设计与样本
- 综合卒中中心分析,纳入422例aSAH患者,其中88例接受莫达非尼(100-200 mg/天),采用重复测量配对检验进行用药前后分析,并用倾向性评分匹配(1:1最近邻)比较莫达非尼组与无莫达非尼组结局。
主要发现
- 莫达非尼使用率为21%(88/422),中位(IQR)疗程10.5(4-16)天,起始时间为aSAH后14(7-17)天。
- 87.5%(77/88)的莫达非尼使用者在72小时内精神状态(警觉性、定向力或GCS评分)改善,出院时86.4%(76/88)改善。
- 37例插管患者中,10例(27%)在莫达非尼起始后72小时内拔管。
- 物理治疗和作业治疗团队注意到56例莫达非尼患者中47例(83.9%)警觉性或参与度提高。
- 倾向性评分匹配基线协变量后,莫达非尼组出院时GCS评分平均(SD)变化为2.2(4.0),无莫达非尼组为-0.2(6.32),P=0.003。
临床怎么用
- 作者认为,这些发现、良好的不良反应谱以及对护理目标决策的意义,支持在急性护理环境中对aSAH患者低阈值起始莫达非尼。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disorders of consciousness impair early recovery after aneurysmal subarachnoid hemorrhage (aSAH). Modafinil, a wakefulness-promoting agent, is efficacious for treating fatigue in stroke survivors, but data pertaining to its use in the acute setting are scarce. This study sought to assess the effects of modafinil use on mental status after aSAH. METHODS: Modafinil timing and dosage, neurological examination, intubation status, and physical and occupational therapy participation were documented. Repeated-measures paired tests were used for a before-after analysis of modafinil recipients. Propensity score matching (1:1 nearest neighbor) for modafinil and no-modafinil cohorts was used to compare outcomes. RESULTS: Modafinil (100-200 mg/day) was administered to 21% (88/422) of aSAH patients for a median (IQR) duration of 10.5 (4-16) days and initiated 14 (7-17) days after aSAH. Improvement in mentation (alertness, orientation, or Glasgow Coma Scale score) was documented in 87.5% (77/88) of modafinil recipients within 72 hours and 86.4% (76/88) at discharge. Of 37 intubated patients, 10 (27%) were extubated within 72 hours after modafinil initiation. Physical and occupational therapy teams noted increased alertness or participation in 47 of 56 modafinil patients (83.9%). After propensity score matching for baseline covariates, the modafinil cohort had a greater mean (SD) change in Glasgow Coma Scale score than the no-modafinil cohort at discharge (2.2 [4.0] vs. -0.2 [6.32], P = 0.003). CONCLUSIONS: A temporal relationship with improvement in mental status was noted for most patients administered modafinil after aSAH. These findings, a favorable adverse-effect profile, and implications for goals-of-care decisions favor a low threshold for modafinil initiation in aSAH patients in the acute-care setting.
引用
- Koester SW, Rumalla K, Catapano JS, et al. Modafinil Therapy and Mental Status Following Aneurysmal Subarachnoid Hemorrhage: Comprehensive Stroke Center Analysis. World Neurosurg. 2024. PMID: 38367859. doi:10.1016/j.wneu.2024.02.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。